Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 1

Interventions

3-ingenyl angelate 42Aminolevulinic Acid 34Imiquimod 29Fluorouracil 23Photochemotherapy 22methyl 5-aminolevulinate 14Gels 12Diclofenac 12Cryotherapy 12tirbanibulin 7Solutions 7BF-200 ALA 6calcipotriene 5Petrolatum 5Ointments 5LEO 43204 5Radiotherapy 4Prilocaine 4Lidocaine 4Therapeutics 3Niacinamide 3Cryosurgery 3Biopsy 31-phenyl-3,3-dimethyltriazene 3Tomography, Optical Coherence 2SR-T100 2Phototherapy 2Imipramine 2Deoxyribonuclease (Pyrimidine Dimer) 2Celecoxib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Keratosis, Actinic × beta-solamarine × Clear all
NCT02559934 2019-07-15

Multiple-dose Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis

G&E Herbal Biotechnology Co., LTD

Phase 1 Completed
12 enrolled
Dermatologic

Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡